The Valley Desk

NCT01933932 · Interventional trial

Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC

Overall registry status Active not recruiting

Phase 3

Conditions Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov